SCHEMBL13190972

SCHEMBL13190972

O=C(NCCN[C@@H](CCCNC1CCCCC1)C(=O)NCC(c1ccccc1)c1ccccc1)c1ccc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 2/20 0.46
▸ CPB2 Q96IY4 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CTSL P07711 1/20 0.42
▸ CTSS P25774 1/20 0.42
▸ CTSK P43235 1/20 0.42
▸ DRD2 P14416 3/20 0.42
▸ DRD3 P35462 3/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ OPRM1 P35372 1/20 0.41
▸ TMEM97 Q5BJF2 1/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ DRD4 P21917 2/20 0.41
▸ METAP2 P50579 2/20 0.40
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13689397 0.85 CXCR4 (0.43) CXCR4CASP1CTSLCTSSCTSK
SCHEMBL13691767 0.83 DRD3 (0.56) DRD2DRD3SLC6A2SLC6A4DRD4
SCHEMBL22545910 0.74 HDAC3 (0.50) DRD2DRD3SLC6A2SLC6A4OPRM1
SCHEMBL13691766 0.73 DRD3 (0.50) DRD2DRD3SLC6A2SLC6A4DRD4
SCHEMBL13691798 0.72 SMYD2 (0.47) DRD2DRD3
SCHEMBL13691769 0.71 OPRM1 (0.46) DRD2DRD3OPRM1TMEM97SIGMAR1
SCHEMBL13691772 0.70 OPRM1 (0.46) DRD2DRD3OPRM1TMEM97SIGMAR1
SCHEMBL22545937 0.70 CHRM2 (0.48) DRD2DRD3OPRM1TMEM97SIGMAR1
SCHEMBL13691765 0.69 NPC1 (0.44) CPB2DRD2DRD3OPRM1TMEM97
SCHEMBL13689401 0.68 OPRM1 (0.45) DRD2DRD3OPRM1TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010096853-A1 METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR MIMETICA PTY LTD (AU) 2010-09-02 — — WO disclosed
Send feedback